Cargando…

UQCRFS1 serves as a prognostic biomarker and promotes the progression of ovarian cancer

UQCRFS1 has been reported to be highly expressed in gastric and breast cancer, but the mechanism remains unclear. The prognosis and biological functions of UQCRFS1 in ovarian cancer (OC) have not been evaluated. The expression of UQCRFS1 in EOC was detected by GEPIA and HPA websites, and the prognos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Qiran, Li, Jiaqi, Dong, Hao, Zhan, Jiao, Xiong, Xiaoming, Ding, Jiashan, Li, Yuan, He, Linsheng, Wang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205806/ https://www.ncbi.nlm.nih.gov/pubmed/37221238 http://dx.doi.org/10.1038/s41598-023-35572-z

Ejemplares similares

Amplification of the UQCRFS1 Gene in Gastric Cancers
por: Jun, Kyong Hwa, et al.
Publicado: (2012)

Construction of a new tumor immunity-related signature to assess and classify the prognostic risk of ovarian cancer
por: Ding, Jiashan, et al.
Publicado: (2020)

UQCRFS1N assembles mitochondrial respiratory complex-III into an asymmetric 21-subunit dimer
por: Zong, Shuai, et al.
Publicado: (2018)

CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2022)

RNA-Binding Motif Protein 11 (RBM11) Serves as a Prognostic Biomarker and Promotes Ovarian Cancer Progression
por: Fu, Chunhong, et al.
Publicado: (2021)

LncRNA ZFAS1 serves as a prognostic biomarker to predict the survival of patients with ovarian cancer
por: Han, Shuang, et al.
Publicado: (2019)

FDX1 serves as a prognostic biomarker and promotes glioma progression by regulating the immune response
por: Zhang, Guangying, et al.
Publicado: (2023)

RGS16 promotes glioma progression and serves as a prognostic factor
por: Huang, Ruoyu, et al.
Publicado: (2020)

ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer
por: Jiao, Yan, et al.
Publicado: (2019)

GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival
por: Yang, Dingquan, et al.
Publicado: (2020)

Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma
por: Yang, Jian, et al.
Publicado: (2022)

Inflammation-Related Genes Serve as Prognostic Biomarkers and Involve in Immunosuppressive Microenvironment to Promote Gastric Cancer Progression
por: Wei, Yuanfeng, et al.
Publicado: (2022)

Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma
por: Xu, Guang-hua, et al.
Publicado: (2018)

SIRT4 and SIRT6 Serve as Novel Prognostic Biomarkers With Competitive Functions in Serous Ovarian Cancer
por: Wang, Huihuan, et al.
Publicado: (2021)

GNPNAT1 promotes the stemness of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2023)

YOD1 serves as a potential prognostic biomarker for pancreatic cancer
por: Zhang, Zhishuo, et al.
Publicado: (2022)

Speculation on optimal numbers of examined lymph node for early-stage epithelial ovarian cancer from the perspective of stage migration
por: Li, Yuan, et al.
Publicado: (2023)

SLC25A11 serves as a novel prognostic biomarker in liver cancer
por: Pan, Guoqiang, et al.
Publicado: (2020)

METTL7B serves as a prognostic biomarker and promotes metastasis of lung adenocarcinoma cells
por: Li, Rong, et al.
Publicado: (2022)

STK3 promotes gastric carcinogenesis by activating Ras-MAPK mediated cell cycle progression and serves as an independent prognostic biomarker
por: Chen, Bonan, et al.
Publicado: (2021)

Extra Spindle Pole Bodies-Like 1 Serves as a Prognostic Biomarker and Promotes Lung Adenocarcinoma Metastasis
por: Nie, Zhi, et al.
Publicado: (2022)

NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2017)

Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma
por: Wang, Jianlin, et al.
Publicado: (2018)

JAK3 and TYK2 Serve as Prognostic Biomarkers and Are Associated with Immune Infiltration in Stomach Adenocarcinoma
por: Meng, Lingkai, et al.
Publicado: (2020)

Actin-Binding LIM 1 (ABLIM1) Inhibits Glioblastoma Progression and Serves as a Novel Prognostic Biomarker
por: Liu, Danping, et al.
Publicado: (2022)

CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
por: Zhou, Huifang, et al.
Publicado: (2019)

Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers
por: Chen, Jing, et al.
Publicado: (2019)

E2F2/5/8 Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer
por: Zhou, Quan, et al.
Publicado: (2019)

Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer
por: Liu, Shuna, et al.
Publicado: (2021)

TEADs serve as potential prognostic biomarkers and targets for human gastric cancer
por: Wang, Meng-huan, et al.
Publicado: (2022)

Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins
por: Gou, Rui, et al.
Publicado: (2019)

PROZ May Serve as a Prognostic Biomarker for Early Hepatocellular Carcinoma
por: Jiang, Xiaocong, et al.
Publicado: (2021)

Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer
por: Li, Zequn, et al.
Publicado: (2021)

Dipetidyl peptidase-4 and transferrin receptor serve as prognostic biomarkers for acute myeloid leukemia
por: Wei, Jie, et al.
Publicado: (2021)

miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway
por: Li, Chuansheng, et al.
Publicado: (2018)

Four Prognosis-Associated lncRNAs Serve as Biomarkers in Ovarian Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2021)

HOXB4 promotes the malignant progression of ovarian cancer via DHDDS
por: Li, Na, et al.
Publicado: (2020)

HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancer
por: Wang, Feng-Jiao, et al.
Publicado: (2021)

CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Tang, Kaihua, et al.
Publicado: (2023)

CDK1 serves as a potential prognostic biomarker and target for lung cancer
por: Li, Mingyao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9nng2n72bitgs69i17jgonvk6q